| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |